oncolytic viruses

AstraZeneca scraps pact with Riva-led Transgene in further blow to oncolytic viruses
Fierce Biotech
Fri, 05/5/23 - 10:18 am
AstraZeneca
oncolytic viruses
Transgene
Oncolytic virus startup TILT raises €22M to advance cancer therapies
Endpoints
Tue, 02/7/23 - 11:05 am
TILT Biotherapeutics
oncolytic viruses
clinical trials
cancer
oncology
In cash saving mode, Oncorus cuts trial, staff, lease, and pipeline
Endpoints
Thu, 12/1/22 - 10:26 am
Oncorus
ONCR-177
layoffs
oncolytic viruses
VacV exits stealth with systemic oncolytic viral delivery tech and vision of immune system stimulation
Fierce Pharma
Mon, 10/31/22 - 10:38 am
VacV Biotherapeutics
Vaccinia
oncolytic viruses
venture capital
Oncolytic virus experts at Replimune reload with $200M loan as biotech collects clinical data
Endpoints
Fri, 10/7/22 - 10:46 am
Replimune
oncolytic viruses
Friendly fire: Using viruses to kill tumors and fight breast cancer
MedCity News
Wed, 01/5/22 - 10:29 am
oncolytic viruses
tumors
cancer
Replimune heads for the liver
EP Vantage
Fri, 06/4/21 - 10:39 am
Replimune
oncolytic viruses
skin cancer
Two Companies Ring in 2021 with Cash for Cancer and Rare Diseases
BioSpace
Tue, 01/5/21 - 10:38 am
funding
biotech
IconOVir Bio
oncolytic viruses
cancer
oncology
Aro Biotherapeutics
RNA
C4's Andrew Hirsch blows up IPO to $182M, while oncolytic virus upstart nabs $87M offering
Endpoints
Sun, 10/4/20 - 12:13 am
C4 Therapeutics
Oncorus
IPOs
oncolytic viruses
Oncorus raises $80M for 2-front oncolytic virus R&D push
Fierce Biotech
Wed, 08/21/19 - 10:42 am
Oncorus
oncolytic viruses
Sillajen explains Pexa-Vec trial failure – it was the rescue meds
Pharmaforum
Tue, 08/6/19 - 10:48 am
SillaJen
oncolytic viruses
Pexa-Vec
SillaJen, Transgene fall with latest oncolytic virus setback
BioCentury
Sat, 08/3/19 - 02:29 pm
Transgene
SillaJen
clinical trials
Pexa-Vec
oncolytic viruses
Oncolytic virus play OncoMyx raises $25M series A
BioCentury
Wed, 06/5/19 - 07:35 pm
OncoMyx
oncolytic viruses
AstraZeneca ups oncolytic virus activity with Transgene deal
Fierce Biotech
Thu, 05/2/19 - 11:22 am
AstraZeneca
Transgene
oncolytic viruses
drug development
J&J’s Janssen acquires cancer-killing virus tech
Drug Delivery Business News
Wed, 05/2/18 - 10:19 am
JNJ
Janssen
BeneVir
oncolytic viruses